These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9521774)

  • 1. Mode of action of site-directed irreversible folate analogue inhibitors of thymidylate synthase.
    Lobo AP; Nair MG; Changchien L; Weichsel A; Montfort WR; Maley F
    Biochemistry; 1998 Mar; 37(13):4535-42. PubMed ID: 9521774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic scheme for thymidylate synthase from Escherichia coli: determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady-state catalysis.
    Spencer HT; Villafranca JE; Appleman JR
    Biochemistry; 1997 Apr; 36(14):4212-22. PubMed ID: 9100016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E58Q.
    Sage CR; Rutenber EE; Stout TJ; Stroud RM
    Biochemistry; 1996 Dec; 35(50):16270-81. PubMed ID: 8973201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
    Anderson AC; Perry KM; Freymann DM; Stroud RM
    J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
    Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
    J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
    Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
    Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional identity of the active sites of crustacean and viral thymidylate synthases.
    Arvizu-Flores AA; Aispuro-Hernandez E; Garcia-Orozco KD; Varela-Romero A; Valenzuela-Soto E; Velazquez-Contreras EF; Rojo-Domínguez A; Yepiz-Plascencia G; Maley F; Sotelo-Mundo RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Sep; 150(3):406-13. PubMed ID: 19559812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2'-deoxyuridylate and 10-propargyl-5,8-dideazafolate.
    Matthews DA; Appelt K; Oatley SJ; Xuong NH
    J Mol Biol; 1990 Aug; 214(4):923-36. PubMed ID: 2201778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.
    Doan LT; Martucci WE; Vargo MA; Atreya CE; Anderson KS
    Biochemistry; 2007 Jul; 46(28):8379-91. PubMed ID: 17580969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase.
    Hanlon MH; Ferone R
    Cancer Res; 1996 Jul; 56(14):3301-6. PubMed ID: 8764125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of Escherichia coli thymidylate synthase at tyrosine-94 by 5-imidazolylpropynyl-2'-deoxyuridine 5'-monophosphate.
    Saxl RL; Reston J; Nie Z; Kalman TI; Maley F
    Biochemistry; 2003 Apr; 42(15):4544-51. PubMed ID: 12693951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity at the substrate activation site of yeast pyruvate decarboxylase: inhibition by distortion of domain interactions.
    Baburina I; Dikdan G; Guo F; Tous GI; Root B; Jordan F
    Biochemistry; 1998 Feb; 37(5):1245-55. PubMed ID: 9477950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural aspects of the inhibition and catalytic mechanism of thymidylate synthase.
    Hardy LW
    Acta Biochim Pol; 1995; 42(4):367-80. PubMed ID: 8852328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D221 in thymidylate synthase controls conformation change, and thereby opening of the imidazolidine.
    Sage CR; Michelitsch MD; Stout TJ; Biermann D; Nissen R; Finer-Moore J; Stroud RM
    Biochemistry; 1998 Sep; 37(39):13893-901. PubMed ID: 9753479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.
    Gangjee A; Jain HD; Kisliuk RL
    Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.